MedTrace Logo

The Effects of Strength and Balance Training on Physical Function in Overweight Children

NCT05665621 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-02-28

No results posted yet for this study

Summary

This intervention study aims to examine the efficacy of a school-based exercise programme to improve strength and balance in overweight and obese 7-11-year-olds in the United Kingdom. The main question\[s\] it aims to answer are:

* Is the school-based exercise programme effective in improving lower limb muscular strength and balance control?
* How do increases in strength and balance skills impact physical function, the risk to musculoskeletal health, and physical activity? Participants will attend baseline, post-intervention, and follow-up testing that includes assessment of strength, balance, 3D gait, plantar pressure, physical function and physical activity. The intervention group will take part in physical activity sessions in their school for 1 hour twice a week for a total of 8 weeks.

Researchers will compare the intervention group to a control group that will take part in no-activity sessions and carry out their normal school and seasonal activities.

Conditions

  • Obesity, Childhood

Interventions

OTHER

Eight-week in-school strength and balance training program

Training program consisting of two 1-hour strength and balance training sessions per week.

Sponsors & Collaborators

  • St. Mary's University, Twickenham

    lead OTHER

Principal Investigators

  • Ryan Mahaffey, PhD · St. Mary's University, Twickenham

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-13
Primary Completion
2023-08-13
Completion
2023-08-13

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05665621 on ClinicalTrials.gov